fda warning letters compounded semaglutide 2025 september Drug compounders sue over declaration ending Wegovy shortage FDA Issues Warning Letters to
Description
I always order from heavily tested sources with long reputations, even if theyre more expensive, one person shared

These lawsuits claim that Eli Lilly did not properly warn patients and doctors about the risks of the drug

Services like GoodRx can offer significant savings on brand-name GLP-1 medications for those paying out-of-pocket. It is essential for patients currently using compounded GLP-1s to have an open conversation with their healthcare provider to explore these alternatives and develop a safe and effective treatment plan moving forward, Ewing added.
Others find that oral semaglutide formulations produce a different side effect profile than injections, though the overall efficacy data differs between delivery methods

Cardiovascular outcomes data: The FDA might want to see cardiovascular outcomes trial results before approval, which could push the date back
